Bristol Myers has struggled to generate growth in recent years. Its high debt load has come down but remains a burden for the ...
Bristol-Myers Squibb Company (NYSE:BMY) is included among the Best Stocks for a Dividend Stock Portfolio. Bristol-Myers Squibb Company (NYSE:BMY) is a pharmaceutical company focused on developing ...
Bristol-Myers Squibb Company (NYSE:BMY) is included among the 12 Best Dividend Stocks with Yields Above 4%. Bristol-Myers Squibb Company (NYSE:BMY), headquartered in New Jersey, is a global ...
Bristol Myers Squibb Co. (Symbol: BMY) has been named a Top Socially Responsible Dividend Stock by Dividend Channel, signifying a stock with above-average ''DividendRank'' statistics including a ...
Bristol Myers Squibb Co. (Symbol: BMY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a staggering $17.02B worth of stock held by ETFs, and above-average ''DividendRank'' ...
Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-two cents ($0.62) per share on the $0.10 par value common stock of the company.
Zacks Investment Research on MSN
Bristol Myers Gains 7.2% in a Month: Buy, Sell or Hold the Stock?
The going has been good for Bristol Myers Squibb BMY over the past month. Shares of this biotech giant have gained 7.2% in a month compared with the industry’s growth of 3.8%. BMY has even ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results